Nazemi, K. J., Shen, V., Finlay, J. L., Boyett, J., Kocak, M., Lafond, D., . . . Nicholson, H. S. (2016). High Incidence of Veno-Occlusive Disease With Myeloablative Chemotherapy Following Craniospinal Irradiation in Children With Newly Diagnosed High-Risk CNS Embryonal Tumors: A Report From the Children's Oncology Group (CCG-99702). Pediatric blood & cancer, 63(9), 1563-1570. https://doi.org/10.1002/pbc.26074
Chicago Style (17th ed.) CitationNazemi, Kellie J., Violet Shen, Jonathan L. Finlay, James Boyett, Mehmet Kocak, Deborah Lafond, Sharon L. Gardner, Roger J. Packer, and H. Stacy Nicholson. "High Incidence of Veno-Occlusive Disease With Myeloablative Chemotherapy Following Craniospinal Irradiation in Children With Newly Diagnosed High-Risk CNS Embryonal Tumors: A Report From the Children's Oncology Group (CCG-99702)." Pediatric Blood & Cancer 63, no. 9 (2016): 1563-1570. https://doi.org/10.1002/pbc.26074.
MLA (9th ed.) CitationNazemi, Kellie J., et al. "High Incidence of Veno-Occlusive Disease With Myeloablative Chemotherapy Following Craniospinal Irradiation in Children With Newly Diagnosed High-Risk CNS Embryonal Tumors: A Report From the Children's Oncology Group (CCG-99702)." Pediatric Blood & Cancer, vol. 63, no. 9, 2016, pp. 1563-1570, https://doi.org/10.1002/pbc.26074.